CD274 and hepatocellular carcinoma: Nonetheless, experiments using the MG132 inhibitor and the glycosylation enzyme inhibitor Tunicamycin in hepatoma cells indicate that glycosylation of PD‐L1 in hepatoma cells can enhance its protein expression, consistent with reports that PD‐L1 glycosylation promotes its stability [27, 41].